US medical device company Abbott has said it plans to launch a new range of ‘biowearable’ health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring.
The new wearable line is called Lingo, a nod to learning how to understand the body’s language. It is being designed to track key biomarkers in the body – namely glucose, ketones, lactate, and eventually alcohol – to help people better understand their general health and take action.